DBV Technologies SA (NAS:DBVT)
$ 3.97 0.07 (1.79%) Market Cap: 74.96 Mil Enterprise Value: 29.75 Mil PE Ratio: 0 PB Ratio: 1.34 GF Score: 39/100

DBV Technologies SA at Evercore ISI HealthCONx Conference Transcript

Dec 01, 2020 / 05:35PM GMT
Release Date Price: $24.4 (-0.41%)
Liisa Ann Bayko
Evercore ISI Institutional Equities, Research Division - Research Analyst

Hi, Daniel. How are you?

Daniel TassÃ;DBV Technologies S.A.;CEO;Director

©,-&

I'm great, Liisa. How are you?

Liisa Ann Bayko
Evercore ISI Institutional Equities, Research Division - Research Analyst

I'm good. So I want to welcome Daniel Tassé, Chief Executive Officer of DBV Technologies. DBV is working in the area of peanut allergy. So a lot of enthusiasm there. Companies had its ups and downs, and I think they're working their way back up right now. So I think we're excited to get into the details. But maybe first, just to set the stage, Daniel, you can tell us a little bit more about DBV.

Daniel TassÃ;DBV Technologies S.A.;CEO;Director

©,-&

Yes. DBV is a company that is exploring the fact that the human skin is actually a pretty powerful immune organ, something that is not always well understood,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot